H.R. 6043 - Fair Accountability and Innovative Research Drug Pricing Act of 2016
- Sponsor:
- Janice D. Schakowsky
- Summary:
- To require reporting regarding certain drug price increases, and for other purposes. (by CRS)
- Status:
- The bill has been referred to committee.
Fair Accountability and Innovative Research Drug Pricing Act of 2016
H.R. 6043 — 114th Congress (2015–2016)
- Summary
- To require reporting regarding certain drug price increases, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- To require reporting regarding certain drug price increases, and for other purposes.
- Other Titles
- Fair Accountability and Innovative Research Drug Pricing Act of 2016
- Fair Accountability and Innovative Research Drug Pricing Act of 2016
- Sponsor
- Janice D. Schakowsky
- Co-Sponsors
- Subjects
- Health
- Civil actions and liability
- Congressional oversight
- Consumer affairs
- Corporate finance and management
- Government information and archives
- Government studies and investigations
- Inflation and prices
- Medical research
- Prescription drugs
- Research and development
- Related Bills
- Major Actions
Introduced 9/15/2016 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 9/15/2016 9/15/2016 Introduced in House 9/15/2016 Referred to the House Committee on Energy and Commerce. Number Sponsor Date Offered Status
Contributions data source: OpenSecrets.org